Triple Therapy for Cystic Fibrosis Phe508del -Gating and -Residual Function Genotypes.

Peter J. Barry,Marcus A. Mall,Antonio Álvarez,Carla Colombo,Karin M. de Winter-de Groot,Isabelle Fajac,Kimberly A McBennett,Edward F. McKone,Bonnie W. Ramsey,Sivagurunathan Sutharsan,Jennifer L. Taylor-Cousar,Elizabeth Tullis,Neil Ahluwalia,Lucy S Jun,Samuel M. Moskowitz,Valentin Prieto-Centurion,S. Tian,David Waltz,Fengjuan Xuan,Yaohua Zhang,Steven M. Rowe,Deepika Polineni

Triple Therapy for Cystic Fibrosis Phe508del -Gating and -Residual Function Genotypes.

2021

Abstract Background Elexacaftor–tezacaftor–ivacaftor is a small-molecule cystic fibrosis transmembrane conductance regulator (CFTR) modulator regimen shown to be efficacious in patients with at lea...

Keywords:

Gating
Cystic fibrosis
Gastroenterology
Genotype
in patient
Internal medicine
Cystic fibrosis transmembrane conductance regulator
Medicine
Function (biology)
2019 20 coronavirus outbreak
Regimen

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations